ClearScope enables clinicians to avoid the need to continuously remove and clean scope during surgery. Credit: © The University of Texas at Austin.

ClearCam has received $4m in seed round funding to expand the commercial reach of its ClearScope system, which improves visualisation and safety in laparoscopic procedures.

The company will also use the funds to scale its operations and make substantial advancements in the field of robotic surgery visualisation.

Go deeper with GlobalData

Premium Insights

The gold standard of business intelligence.

Find out more

Related Company Profiles

View all

Led by the family office of Texas real estate developer Hal Jones, the round also involved other participants including the University of Texas at Austin Seed Fund.

Jones said: “I am thrilled to have the opportunity to invest in ClearCam’s team and their mission to make surgery safer and more efficient.

“Activating the potential for growth in the medtech and engineering sectors in Austin is something we are excited to participate in. ClearCam is a team maximising this potential.”

See Also:

ClearScope is a disposable in-vivo laparoscopic lens cleaner that allows clinicians to avoid the need for repetitive scope removal and cleaning during surgery. It empowers surgeons to maintain their visual field and momentum during surgical procedures.

How well do you really know your competitors?

Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.

Company Profile – free sample

Thank you!

Your download email will arrive shortly

Not ready to buy yet? Download a free sample

We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form

By GlobalData
Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

The system also helps in decreasing time spent by a patient in the operating room (OR), while also enhancing surgical safety.

The device has been deployed in nearly 2,000 procedures nationwide and its usage is increasing in thoracic, general and gynecologic surgeries.

ClearScope has been adopted by multiple hospital systems in Texas and Michigan, while many others are awaiting access and trials.

ClearCam will use the funds from this round to expand its sales and business development initiatives.

ClearCam CEO and co-founder Dr John Uecker said: “ClearScope offers surgeons and OR staff an improved, streamlined and simplified solution to clean their laparoscopes in-vivo. It is a win-win and we look forward to launching the improved product in June.”